Indusken Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 25-12-2024
- Paid Up Capital ₹ 2.52 M
as on 25-12-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 1.20 M
as on 25-12-2024
About Indusken Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.52 M.
The company currently has active open charges totaling ₹1.20 M.
Narendra Deshmukh and Anjani Deshmukh serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC139032
- Company No.
139032
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2003
- Date of AGM
30 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indusken Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Deshmukh  | Managing Director | 05-Feb-2003 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjani Deshmukh | Director | 23-Feb-2006 | Current |
Financial Performance of Indusken Pharmaceuticals.
Enhance accessibility to Indusken Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Indusken Pharmaceuticals?
Unlock access to Indusken Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Nov 2003 | Bank Of Maharashtra | ₹1.20 M | Open |
How Many Employees Work at Indusken Pharmaceuticals?
Indusken Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indusken Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indusken Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
